Approval · Notice of Compliance 8018 · 2006
APO-DIGOXIN: Notice of Compliance 8018
Issued June 12, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8018
- Date
- June 12, 2006
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Cardiotonic glycoside
- Canadian reference product
- LANOXIN (Virco Pharmaceuticals (Canada) Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-DIGOXIN | 02281201 | Dormant |
| APO-DIGOXIN | 02281236 | Dormant |
| APO-DIGOXIN | 02281228 | Dormant |